TRBV9-targeted bispecific T cell engagers

TRBV9-targeted T cell engaging antibodies are a precision immunotherapy for the selective elimination of autoreactive T cells in ankylosing spondylitis and celiac disease.

Previous
Previous

9G4-targeted bispecific T cell engagers and CAR-T cells